Small Cap Feast
Small Cap Feast – 07 October 2019
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
Stride Gaming (STR) – has delisted due to being acquired by Rank Group at 151p per share.
Stride Gaming (STR) – has delisted due to being acquired by Rank Group at 151p per share.
What’s Cooking in the IPO Kitchen?
Main Market Standard
Kaspi.kz, the largest Payments, Marketplace and Fintech Ecosystem in Kazakhstan with a leading market share in each of its key products and services. GDR offering expected Oct 2019. In the first half of 2019, the Company generated total revenue of KZT226,862m (U.S. $598m), up 34% and net income of KZT77,001m (U.S. $203m), up 54%.
Main Market premium
Registration document approved for Helios Towers. The Group provides essential network services, flexible infrastructure solutions and reliable power supply to mobile network operators in five African growth economies. Revenue increased 7 per cent. year-on-year to US$191m (H1 2018: US$178m), with Adjusted EBITDA up 15 per cent. year-on-year at US$99m (H1 2018: US$86m) for the six months ended 30 June 2019. Pricing rumoured at 115p to 145p implying valuation of up to $1.8bn
Petards Group* (PEG) 15p £8.62m
Petardshas been awarded a contract to supply Bombardier Transportation with Petards eyeTrain syste ms. The new contract, which is worth £1.3m is for the supply of Petards eyeTrain systems to be fitted to BOMBARDIER ELECTROSTARTM Electric al Multiple Unit (EMU) trains as part of an upgrade programme with train owner Porterbrook and train operator Govia Thameslink Railway (GTR). The upgrade will further enhance the ELECTROSTAR’S video and data collection capability through the addition of the Petards eyeTrain Forward Facing CCTV, Track Debris/ Third Rail Camera and Digital Video Recording (DVR) systems. Activities will commence immediately with the first equipment deliveries starting early 2020 and it is expected that the deliveries will be completed in 2021.
Argentex Group (AGFX) 150p £158.5
Argentex Group, the recently listed provider of foreign exchange services to institutions, corporates and high net worth private individuals, today issues a Trading Update for the first half of the financial year ending 30 September 2019. Argentex continued to build on its strong track record of growth during the period, generating revenues of £9.3m from 25 June 2019 to 30 September 2019, the period since the Group’s admission to the AIM market of the London Stock Exchange. Underlying revenues for Argentex LLP, the Group’s FCA regulated trading subsidiary, for the full sixmonth period to 30 September 2019 were £13.8m, an increase of 45% compared to Argentex LLP’s H1 2018 results (£9.5m).
Crossword Cybersec* (CCS) 410p £20.6m
Crossword Cybersecurity note that two Senior team members are included in this year’s Evening Standard Progress 1000 – their list of the 1000 most influential people in London. The Progress 1000, in partnership with the global bank Citi, is the Evening Standard’s celebration of the people changing London’s future for the better. Both CEO, Tom Ilube CBE and Senior Adviser, Professor Nick Jennings are included in the list. Both influencers have made the Cyber Security list, a subset of the Progress 1000 aimed at those having particular influence in Technology and Cyber Security.
Steppe Cement (STCM) 27.5p £64m
Market Update for the Third Quarter ended 30 September 2019 Third quarter 2019 revenue of KZT 10,560m was 10% lower than revenue of KZT 11,696m achieved in the corresponding quarter in 2018. For the 9 months ended 30 September 2019, Steppe Cement Ltd recorded revenue of KZT 24,639m compared with KZT 22,416m in the corresponding 9-month period in 2018, representing a 10% increase. A sales volume of 576,692 tonnes was achieved during the third quarter, an 11% decrease from the third quarter of 2018 due to prioritising price vs volume in the third quarter. For the first 9 -months of 2019, the sales volume decreased by 2% to 1,357,007 tonnes from 1,386,989 tonnes in the corresponding 9-month period in 2018.
Intercede Group (IGP) 23.4p £16.66m
Trading update: Intercede, the leading specialist in digital identity, credential management and secure mobility, reports further good progress following last year’s return to profit. Revenues for the six months ended 30 September 2019 are approximately 5% higher than last year. This is in line with expectations and reflects a strong end to the half with orders received from both new and existing customers resulting in revenues of £4.4m (2018: £4.2m). They also report that continued tight cost control has resulted in a positive operating cashflow during the period with cash balances as at 30 September 2019 totalling £5.2m compared to £3.2m as at 31 March 2019.
TP Group (TPG) 6.75p £50m
TP Group, the providers of mission-critical solutions for a more secure world, announces that it has been appointed as a key part of the team which has won the Ministry of Defence Skynet Client Side Support contract. This arrangement has been confirmed with the issue of the first task orders, with a committed value of £1.5million to be delivered over the next 12 months. Working with the prime contractor for CSS, PA Consulting, TP Group is providing technical assurance, approvals, analysis and cost estimation expertise to the third largest acquisition project in MOD. The full CSS contract is planned to last for 5 years and has an advertised value of £150m.
CEPS (CEPS) 28.5p £4.84m
CEPS announces that its subsidiary company, Signature Fabrics Limited, has acquired 90 per cent of the issued share capital of a newly incorporated company, Milano International Holdings Limited, which has been formed to acquire 100 per cent of the issued share capital of Milano International Limited, trading as Milano Pro Sport, for a consideration of £1,850,000. Milano was established in 1996 and is based in Preston, Lancashire. The company is one of the leading providers in the design and manufacture of athletic and gymnastic leotards and costumes. Milano FY May 18 : sales were £1,683,570, EBITDA was £110,462 and profit before taxation was £92,881. EBITDA reflects significant one-off costs to the business during that reporting period.
Ramsdens Holdings (RFX) 195p £60m
Ramsdens announced that it has continued to trade well and that the Group’s profit performance has been in line with the Board’s expectations during the six months ended 30 September 2019. This outcome again reflects the strength of the Group’s business model and diversified income streams. In addition to this good trading performance, during the first half, Ramsdens’ management took the decision to scrap some of the Group’s slowermoving jewellery stock to take advantage of a relatively high gold price. As a result, the Group will report an additional, nonrecurring gross profit of approximately £600,000 in its first half results.
Totally PLC (TLY) 9.45p £16.5m
Totally, the provider of a range of services to the healthcare sector in the UK, announced two contract extensions, worth a total of c. £16.6m, awarded to its wholly-owned subsidiary Vocare Limited, one of the UK’s leading national specialist providers of urgent care services.
genedrive (GDR) 17.5p £6m
Full ethics approval from the NHS Health Research Authority and ethics committee has been received for the use of the Company’s Antibiotic Induced Hearing (AIHL) test in hospital trials for clinical validation. The Company believes that this represents the world’s first ethical approval for a point of care genetic test used to influence neonatal management in an acute setting.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.